NATIONAL COVID

Researchers published the results of the first “human challenge study” regarding COVID.

Americans who work at companies with 100 or more employees will need to be fully vaccinated against COVID-19 by January 4, 2022 or get tested for the virus weekly.

Americans who work at companies with 100 or more employees will need to be fully vaccinated against COVID-19 by January 4, 2022 or get tested for the virus weekly.

U.S. health advisers have endorsed kid-size doses of Pfizer’s COVID-19 vaccine for young children.

Johnson and Johnson is formally asking the FDA to authorize a booster for its COVID-19 vaccine.

Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra dose only for those who are 65 or older or run a high risk of severe disease.

The White House COVID-19 Response Team held a briefing on Tuesday (Aug. 31) and covered a wide range of topics.

The White House COVID Response Team said that if you’ve been hesitant to get vaccinated, now is the time.

Children’s camps in multiple states have all experienced COVID outbreaks.

New coronavirus cases are on the rise in nearly every state across the United States.

As of Monday, 61.4% of Michigan adults have received at least one COVID vaccine dose.

Nationwide, the White House COVID-19 Response Team said that nearly 30 percent of American adults and nearly two-thirds of seniors have received at least their first shot of the vaccine. “We are looking at this data carefully. We’re taking all of those data carefully and revisiting our guidance in that context,” she said. A new CDC report found that 96 percent of people are getting their second dose of vaccine within the recommended time frames. Only 3 percent missed their second dose.

READ: US tops 100M doses of COVID-19 vaccine in armsAlaska, meanwhile, is already allowing everyone to sign up for a shot. Ron DeSantis said before Biden spoke Thursday night that all adults could be eligible by next month, while Colorado Gov. AdBut several governors cautioned it must come with a dramatic increase in vaccine supply. Now, an average of 2.2 million doses are being administered per day. California is dedicating at least 40% of its vaccine doses to people in roughly 400 low-income ZIP codes.

Nov. 18, 2020: Local 4 assignment editor shares experience with COVID-19 vaccine trialLocal 4 assignment editor Matt Triplett said he wanted to do everything he could to help end the pandemic and get us back to a more normal life. “I talked to several people I trust and this is just the right thing to do.”AdWhile most of the world has watched and waited for a vaccine, Triplett decided to help make it happen. After researching various trials, he signed up for a Pfizer vaccine study without hesitation. AdOn Feb. 3, he received his second dose of the Pfizer vaccine. “If you get your chance, please go get the vaccine,” Triplett said.

DETROIT – The Michigan Department of Health and Human Services reported Michigan’s first case of the more easily spread U.K. coronavirus variant. and was identified in a Washtenaw County woman who had recently traveled to the U.K. That’s where the variant originated. READ: First case of COVID variant detected in Michigan: What to knowThe B.1.1.7 variant of the virus that causes COVID-19 has quickly become dominant in the U.K. That’s because it appears to be at least 50 percent more transmissible. The reason it’s more easily spread is that several of the mutations in the variant allow the spike protein, which the virus uses to attach to human cells, to bind more tightly. variant does spread more easily.

(AP Photo/Bill Sikes, file)WASHINGTON – A second COVID-19 vaccine has won backing from the U.S. expert panel, paving way for final FDA decision on emergency use. A key FDA panel voted on Thursday and recommend the approval of Moderna’s COVID-19 vaccine for emergency use. Live stream: FDA panel meets to vote on Moderna COVID vaccine authorization2nd COVID-19 vaccine set for OK in US with panel endorsementWritten by the Associated PressWASHINGTON (AP) -- A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign. A second vaccine is urgently needed as coronavirus infections, hospitalizations and deaths climb to new highs ahead of the holidays. Like the first vaccine, Moderna’s vaccine will remain experimental as the company continues a two-year study needed to answer key questions, including how long protection lasts.

DETROIT – The FDA’s vaccine advisory committee spoke at length about the ethics of what should happen to those that took the placebo in Pfizer’s vaccine trial. RELATED: Michigan plans for COVID-19 vaccine: What to expect nextShould they now be permitted to get the actual vaccine? Local 4 assignment editor Matt Triplett said he’s ecstatic that Pfizer’s vaccine will soon be available for the first groups of high-priority Americans. Essentially, everyone in the trial is vaccinated again with those who got the placebo the first time getting the vaccine and vice-versa. It doesn’t just impact Pfizer’s trial.

WARREN, Mich. – A Metro Detroit woman is part of Operation Warp Speed, the team that’s working to push the COVID-19 vaccine to people across the country. After months of logistical planning, Operation Warp Speed must now leap into practice. Waren’s Marion Whicker is on loan to the government from TACOM and she has been part of the logistical planning. The first lot that will leave Pfizer will be 6.5 million doses. Pfizer will continue to ramp up production so that by Dec. 20 there should be another 12 to 15 million doses available to be shipped from Kalamazoo.

DETROIT – The data from vaccine-maker Pfizer that the Food and Drug Administration will be relying on to make a decision about an Emergency Use Authorization this Thursday was made public on Tuesday. The 92-page document and the FDA’s 53-page briefing document are full of details on who received the vaccine and how effective it was. The summary lays out the demographics for the nearly 38,000 study participants, half of which received the vaccine and half of which receive a placebo. Two doses of the Pfizer-BioNTech vaccine are administered 21 days apart. The primary question was how effectively can the vaccine prevent COVID-19 infection 7 days after the second dose of the vaccine?

DETROIT – The first COVID-19 vaccine could potentially be rolled out by mid-December, but local health system leaders voiced their concern Friday about recent polls that suggest people may be reluctant to get it. In a briefing Friday, Henry Ford’s chief clinical officer Dr. Adnan Munkarah said addressing those concerns is a top priority. “People ask me am if I’m going to take the vaccine, I’m going to say, ‘Absolutely, yes. The minute the FDA has us gives us the proof that there’s a vaccine that is effective and safe,’” Munkarah said. But there is a concern that many in the community will be hesitant to take the vaccine.

DETROIT – A Centers for Disease Control and Prevention advisory panel will meet on Tuesday to decide who should get vaccinated for COVID-19 first when a vaccine is made available. The panel is expected to advise that the country’s 21 million health care workers should receive a vaccine before anyone else. Residents of nursing homes and other long-term care facilities are also likely to be the first in line. Ultimately, each state will decide how vaccines are distributed -- but most are expected to follow CDC recommendations. Officials said it will take several months to immunize everyone who wants the vaccine.

ANN ARBOR, Mich. – Pfizer and BioNTech submitted their COVID-19 vaccine to the FDA to be considered for an emergency-use authorization Friday. In 2018, he showed Local 4 his “Flu Lab” at the University of Michigan School of Public Health. Monto will lead the committee that will advise the FDA on whether or not to grant an emergency-use authorization for any coronavirus vaccines. RELATED: Local 4 assignment editor shares experience with COVID-19 vaccine trialThe FDA is not required to follow the recommendation of its advisory committee, but it typically does. “It’s an intellectual pressure, not a political pressure,” Monto said.

DETROIT – Pfizer announced on Wednesday that it is ready to submit its COVID-19 vaccine to the Food and Drug Administration (FDA) for review. The drugmaker reported that its final analysis finds the vaccine is 95 percent effective. READ: Pfizer: COVID-19 shot 95% effective, seeking clearance soonLocal 4 assignment editor Matt Triplett said he wanted to do everything he could to help end the pandemic and get us back to a more normal life. “I talked to several people I trust and this is just the right thing to do.”While most of the world has watched and waited for a vaccine, Triplett decided to help make it happen. Triplett still doesn’t know if he received the actual vaccine or a placebo.

WASHINGTON – President-elect Joe Biden is set to hold a virtual roundtable event with frontline health care workers. House Majority Leader Steny Hoyer, D-Md., and No. They included congresswoman-elect Nikema Williams, who won the Atlanta-area district represented by Democratic Rep. John Lewis, the civil rights champion, until his death in July. 1 and 2 House Democrats since 2003, while Clyburn rose to the No. To prevent lawmakers from crowding unsafely into one room, Democrats' leadership candidates were delivering remarks to scattered lawmakers using Zoom, the online meeting platform.

WASHINGTON – Moderna announced that it’s candidate for a COVID-19 vaccine is nearly 95 percent effective. READ: What does COVID-19 vaccine effectiveness mean? Moderna and Pfizer could roll out 70 million doses worldwide in the coming weeks. Officials in the United States said a little more than 20 million people could get their first shot before the end of the year. A poll conducted after the Pfizer announcement, but before the news from Moderna, found 60 percent of Americans are likely to get the COVID-19 vaccine.

DETROIT – Several dance companies have been shuttered by COVID-19, which means there won’t be any big holiday productions, but a national nonprofit is calling for home videos and rehearsal reels to splice together a virtual version of “The Nutcracker.”The Universal Ballet Competition is calling all dancers from every corner of the world. It’s a nonprofit that promotes dance, scholarships and keeping the artform infused with talent. They have figured out a way to make “The Nutcracker” virtual this year. They’re asking for dance companies of all sizes, with all ages, and varying experience levels to enter their competition. You can contact The Universal Ballet Competition by calling this number: 305-582-7877READ: More entertainment coverage

DETROIT – With increasing COVID-19 cases, there’s a distinct possibility that someone in your home could test positive for coronavirus. If they do, a new paper from the Centers for Disease Control and Prevention show there’s a good chance COVID-19 will spread to other family members, and quickly. But so is the positivity rateWhen you’re in public you can use a mask and social distance yourself to reduce the spread of coronavirus. The CDC did a study following 101 households that began with just one confirmed case of COVID-19. More than half of people living with those patients went on to test positive and the spread was fast.

DETROIT – When it comes to credible and reliable information on the status of the coronavirus (COVID-19) pandemic, no voice is more trusted than Dr. Anthony Fauci. Fauci was interviewed on Wednesday by the editor of the Journal of the American Medical Association (JAMA). Fauci does interviews with the JAMA on a fairly regular basis. They discussed topics as straightforward as his thoughts on the upcoming holiday season. Fauci addressed the question on so many Americans' minds: When can the country get back to normal?